Article // Intelligence
FutureFemHealth · Sep 17, 2026 · Anna O'Sullivan
What if vaginal microbiome testing becomes routine?
Evvy’s $40m Series B sent me looking at where the vaginal microbiome market goes next - and what becomes valuable as testing moves closer to healthcare.
Engagement
Likes: 12
Comments: 0
Restacks: 0
Entities
Entity links appear after intelligence graph backfill.
Sponsorship
No sponsorship detected
Related articles
The new push to build the missing foundations for women’s health research
FutureFemHealth · Same publication
My Normative expands Persons Project to tackle how women’s health data is recorded and shared
FutureFemHealth · Same publication
💌 Teal Health raises $22m, $1.1bn women’s health hospital + EU funding push
FutureFemHealth · Same publication
Bird&Be raises $13m to expand access to fertility care
FutureFemHealth · Same publication
Teal Health raises $22m Series A to expand at-home HPV screening
FutureFemHealth · Same publication
Blair Health raises CAD $4.24m to expand specialist women’s healthcare model
FutureFemHealth · Same publication
European Parliament backs report calling for dedicated women's health funding in next EU budget
FutureFemHealth · Same publication
The cost of censorship: digital restrictions are hitting women’s health businesses
FutureFemHealth · Same publication